Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $6.88 Million - $7.65 Million
-32,912 Reduced 10.12%
292,155 $63.8 Million
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $6.28 Million - $7.22 Million
-31,767 Reduced 8.9%
325,067 $73.9 Million
Q3 2023

Nov 09, 2023

SELL
$201.05 - $221.7 $4.66 Million - $5.14 Million
-23,173 Reduced 6.1%
356,834 $71.7 Million
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $20.4 Million - $23.2 Million
-96,328 Reduced 20.22%
380,007 $91.7 Million
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $16.9 Million - $20.5 Million
79,391 Added 20.0%
476,335 $109 Million
Q4 2022

Feb 13, 2023

SELL
$203.72 - $248.97 $6.87 Million - $8.4 Million
-33,727 Reduced 7.83%
396,944 $93.4 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $3.69 Million - $4.73 Million
18,037 Added 4.37%
430,671 $88.2 Million
Q2 2022

Aug 11, 2022

SELL
$213.86 - $277.87 $8.63 Million - $11.2 Million
-40,338 Reduced 8.91%
412,634 $96.7 Million
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $6.56 Million - $7.53 Million
-25,266 Reduced 5.28%
452,972 $119 Million
Q4 2021

Feb 11, 2022

SELL
$271.6 - $314.21 $677,098 - $783,325
-2,493 Reduced 0.52%
478,238 $150 Million
Q3 2021

Nov 04, 2021

SELL
$274.82 - $308.34 $9.8 Million - $11 Million
-35,663 Reduced 6.91%
480,731 $135 Million
Q2 2021

Aug 11, 2021

BUY
$251.87 - $278.14 $10.7 Million - $11.8 Million
42,532 Added 8.98%
516,394 $142 Million
Q1 2021

May 13, 2021

BUY
$204.88 - $255.03 $32.8 Million - $40.8 Million
159,960 Added 50.96%
473,862 $121 Million
Q4 2020

Feb 16, 2021

SELL
$186.91 - $214.42 $36.2 Million - $41.6 Million
-193,906 Reduced 38.18%
313,902 $63.9 Million
Q3 2020

Nov 12, 2020

BUY
$167.03 - $201.3 $31.6 Million - $38.1 Million
189,461 Added 59.51%
507,808 $95.6 Million
Q2 2020

Aug 13, 2020

BUY
$113.31 - $182.44 $2.94 Million - $4.74 Million
25,985 Added 8.89%
318,347 $52.9 Million
Q1 2020

May 14, 2020

BUY
$104.32 - $195.28 $2.91 Million - $5.45 Million
27,924 Added 10.56%
292,362 $37 Million
Q4 2019

Feb 14, 2020

SELL
$163.48 - $173.61 $15.4 Million - $16.4 Million
-94,380 Reduced 26.3%
264,438 $44.7 Million
Q3 2019

Nov 14, 2019

SELL
$159.77 - $178.1 $19.8 Million - $22.1 Million
-123,947 Reduced 25.67%
358,818 $60.3 Million
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $7.76 Million - $9.31 Million
-53,827 Reduced 10.03%
482,765 $83.5 Million
Q1 2019

May 15, 2019

SELL
$123.7 - $156.3 $15.2 Million - $19.3 Million
-123,229 Reduced 18.68%
536,592 $82.1 Million
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $24.3 Million - $35 Million
-201,024 Reduced 23.35%
659,821 $83.4 Million
Q3 2018

Dec 21, 2021

BUY
$167.67 - $188.27 $46.1 Million - $51.8 Million
274,972 Added 46.93%
860,845 $150 Million
Q3 2018

Nov 14, 2018

SELL
$167.67 - $188.27 $18.3 Million - $20.5 Million
-108,890 Reduced 15.67%
585,873 $102 Million
Q2 2018

Apr 21, 2020

BUY
$160.33 - $189.41 $45.6 Million - $53.9 Million
284,720 Added 69.44%
694,763 $125 Million
Q2 2018

Aug 14, 2018

SELL
$160.33 - $189.41 $135 Million - $159 Million
-839,872 Reduced 67.19%
410,043 $73.6 Million
Q1 2018

Oct 18, 2019

BUY
$161.53 - $178.11 $66.6 Million - $73.4 Million
412,073 Added 49.18%
1,249,915 $202 Million
Q1 2018

May 15, 2018

BUY
$161.53 - $178.11 $58.9 Million - $64.9 Million
364,507 Added 77.01%
837,842 $136 Million
Q4 2017

Feb 14, 2018

BUY
$147.99 - $163.95 $7.25 Million - $8.03 Million
48,981 Added 11.54%
473,335 $75.5 Million
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $63.4 Million - $68.1 Million
424,354
424,354 $64.1 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.